CNBC October 11, 2024
Key Points
– About 165 million Americans rely on employer-sponsored health insurance, and yet workers may still not get the coverage they want — particularly when it comes to drugs such as Wegovy and Ozempic.
– Currently, less than half of employers cover the expensive weight-loss medications.
– Even those that do cover them have guardrails in place that restrict access.
About 165 million Americans rely on employer-sponsored health insurance, and yet workers may still not get the coverage they want — particularly when it comes to drugs such as Novo Nordisk’s weight-loss drug Wegovy and diabetes drug Ozempic.
About 1 in 3 employees are looking for more resources to combat obesity, according to a recent report by consulting firm...